Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2022–2027 · cooperative agreement · U24
The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data
Rehan Akbani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
TBEL Project 2
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
TBEL Admin Core
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Tumor hypoxia promotes acquired resistance to radiation through ferroptosis inhibition
Albert Koong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Administrative Core
Jeffrey Nicholas Myers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Defining the role of KEAP/NRF2 signaling dysregulation and sensory nerve reprograming during acquisition of cisplatin resistance and metastasis in HNSCC
Abdullah Ali Osman · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Molecular Imaging Core
David Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Molecular Imaging Core
David Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Tumor Model and Biospecimen Repository Core
Adel K. El-Naggar · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Administrative Core
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Ferroptosis resistance as a key driver in acquired radiation resistance
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Tumor hypoxia promotes acquired resistance to radiation through ferroptosis inhibition
Dadi Jiang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Ferroptosis resistance as a key driver in acquired radiation resistance
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Metabolic adaptation enables cisplatin resistance and inhibits tumor immunity
Vlad C Sandulache · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Administrative Core
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Metabolic adaptation enables cisplatin resistance and inhibits tumor immunity
Vlad C Sandulache · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Administrative Core
Jeffrey Nicholas Myers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers
Stephen Y Lai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
Jianjun Gao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
Giannicola Genovese · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Pro-Drug Enolase Inhibitors in Precision Oncology
Steven W Millward · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2025 · grant · Standard Grant
Collaborative Research: CPS: Medium: A CPS approach to tumor immunomodulation; sensing, analysis, and control to prime tumors to immunotherapy
Rahul Sheth · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2021–2027 · research · R33
A Squirrel Monkey Model of Alzheimer’s Disease: Developing Behavioral, Blood, and CSF Biomarkers
William D Hopkins · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
RNase H2 is a novel therapeutic target in triple negative breast cancer
Shiaw-Yih Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer
Humam Kadara · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
RNase H2 is a novel therapeutic target in triple negative breast cancer
Shiaw-Yih Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Systematic dissection of function and mechanism of long non-coding RNAs in glioblastoma
Yiwen Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer
Min Sup Song · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
Jlenia Guarnerio · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Peer-Based Approaches to Enhance Physical Activity in Dyads of Inactive Women
Larkin Strong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2024 · fellowship · F32
INVESTIGATING THE ROLE OF HSP90 IN SHAPING THE CONSEQUENCES OF BRCA1 MUTATIONS
Brant Gracia · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Promoting HPV Vaccination among Young Adults in Texas
Qian Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · career development · K08
Impact of clonal hematopoiesis mutations on toxicity and outcomes following oncologic therapy
Kevin Thomas Nead · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · career development · K01
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy
Noha Abdelwahab Hassan Ali Hassan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2024 · fellowship · F32
Elucidating the role of gut, blood, and tumor microbiota in brain metastasis
Golnaz Morad · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
Jianjun Gao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
Hesham M Amin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2024 · fellowship · F31
Resisting food temptation: how do affective and cognitive brain systems interact?
Kyla Gibney · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Radiomic and genomic predictors of breast cancer risk
Laurel A Habel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · grant · S10
Photon Counting Detector MicroCT
Rick Robert Layman · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
